Cheng Liu

发表

Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy.

C. Liu, K. Janda, Pengfei Jiang, 2011, Cancer research.

Targeting tumor-associated macrophages as a novel strategy against breast cancer.

C. Liu, R. Xiang, He Zhou, 2006, The Journal of clinical investigation.

Prostate-specific membrane antigen directed selective thrombotic infarction of tumors.

R. Santucci, R. Vessella, T. Edgington, 2002, Cancer research.

Targeting cell-impermeable prodrug activation to tumor microenvironment eradicates multiple drug-resistant neoplasms.

Ralph R. Reisfeld, C. Liu, K. Janda, 2006, Cancer research.

Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy.

Cheng Liu, C. Liu, K. Janda, 2003, Cancer research.

The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: a potential therapeutic opportunity for atherosclerotic thrombosis.

S. Kesari, C. Liu, Pengfei Jiang, 2014, Thrombosis research.

A hybrid fibronectin motif protein as an integrin targeting selective tumor vascular thrombogen.

C. Liu, T. Edgington, W. Ruf, 2004, Molecular cancer therapeutics.

Factor Xa Binding to Annexin 2 Mediates Signal Transduction via Protease-Activated Receptor 1

C. Liu, N. Mackman, R. Pawlinski, 2008, Circulation research.

The Legumain Protease‐Activated Auristatin Prodrugs Suppress Tumor Growth and Metastasis without Toxicity

C. Liu, S. Sinha, Krishna Mohan Bajjuri , 2011, ChemMedChem.

The Role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression

C. Liu, R. Xiang, He Zhou, 2009, Oncogene.

Regulation of Tissue Factor—Mediated Initiation of the Coagulation Cascade by Cell Surface Grp78

C. Liu, N. Mackman, B. Pedersen, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Prostate-specific Membrane Antigen Directed Selective Thrombotic Infarction of Tumors 1

R. Santucci, R. Vessella, C. Liu, 2002 .

Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug.

C. Liu, Yuan Liu, S. Sinha, 2012, Molecular pharmaceutics.

Selective ablation of tumor‐associated macrophages suppresses metastasis and angiogenesis

C. Liu, Yuan Liu, Yingying Lin, 2013, Cancer science.

In vivo interrogation of the molecular display of atherosclerotic lesion surfaces.

Cheng Liu, C. Liu, T. Edgington, 2003, The American journal of pathology.

Synthesis of the next-generation therapeutic antibodies that combine cell targeting and antibody-catalyzed prodrug activation

C. Barbas, R. Lerner, C. Liu, 2007, Proceedings of the National Academy of Sciences.

A DNA vaccine targeting Fos-related antigen 1 enhanced by IL-18 induces long-lived T-cell memory against tumor recurrence.

C. Liu, R. Xiang, He Zhou, 2005, Cancer research.

Synthesis and evaluation of the aldolase antibody-derived chemical-antibodies targeting α5β1 integrin.

R. Lerner, C. Liu, Yuan Liu, 2013, Molecular pharmaceutics.

A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas

M. Karin, S. Maeda, T. Edgington, 2007, Oncogene.

Legubicin a Tumor-activated Prodrug for Breast Cancer Therapy

Cheng Liu, Cheng Liu, 2008 .

Chemically Programmed Bispecific Antibody Targeting Legumain Protease and αvβ3 Integrin Mediates Strong Antitumor Effects.

C. Liu, Yuan Liu, S. Sinha, 2015, Molecular pharmaceutics.

Chemically Programmed Bispeci fi c Antibody Targeting Legumain Protease and α v β 3 Integrin Mediates Strong Antitumor E ff ects

C. Liu, Yuan Liu, S. Sinha, 2015 .

The Legumain Protease‐Activated Auristatin Prodrugs Suppress Tumor Growth and Metastasis without Toxicity

S. Sinha, Krishna Mohan Bajjuri , Yuan Liu , 2011, ChemMedChem.

Synergism of Selective Tumor Vascular Thrombosis and Protease Activated Prodrug

C. Liu, Cheng Liu, 2008 .

A novel vascular endothelial growth factor heparin-binding domain substructure binds to glycosaminoglycans in vivo and localizes to tumor microvascular endothelium.

T. Edgington, Haining Huang, Cheng Liu, 2002, Cancer research.